# Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

> **NCT05340465** · PHASE2 · RECRUITING · sponsor: **University of Washington** · enrollment: 120 (estimated)

## Conditions studied

- Prematurity
- Iron-deficiency
- Iron Deficiency Anemia
- Iron Malabsorption

## Interventions

- **DRUG:** Darbepoetin Alfa
- **DRUG:** Low Molecular Weight Iron Dextran
- **DRUG:** Ferumoxytol injection
- **DRUG:** Oral iron supplements

## Key facts

- **NCT ID:** NCT05340465
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-27
- **Primary completion:** 2026-10-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05340465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05340465, "Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05340465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*